Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Wilmington, NC MSA — October 2026
Wilmington pays a regulatory premium while CRA pay lags national market.
Metro regulatory affairs pay climbed to $119,186 against a falling $103,780 national figure, while clinical research associate pay at $73,589 still trails the $90,065 national median by roughly $16,500.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- New Hanover County unemployment: 3.3% — Aug 2026, down 0.4pt YoY; vs 4.2% national
- Regulatory Affairs Specialist pay, metro: $119,186 — Up significantly vs national $103,780 (down)
- Clinical Research Associate pay, metro: $73,589 — Up locally, but $16,476 below national $90,065
- NC life sciences investment since 2022: $19B / 91 projects — 10,000+ jobs announced, incl. Amgen, J&J
Key takeaways
Regulatory affairs pay is pulling ahead locally while the national market cools.
Wilmington's regulatory affairs median rose to $119,186 against a declining $103,780 national figure, a divergence consistent with EU/UK regulatory reform and EUDAMED rollout pressure cited nationally. Employers holding regulatory headcount flat risk losing talent to organizations treating this role as a retention priority.
CRA pay gap with the national market signals a recruiting vulnerability.
Metro CRA advertised pay reached $73,589, up locally, but remains roughly $16,500 below the national median of $90,065. With national CRA demand described as candidate-driven and experienced professionals as the bottleneck, this gap may make it harder to backfill departures with experienced hires, leaving entry-level staff to fill the gap instead.
Lab technician pay softened even as the role stays operationally essential.
Metro lab technician advertised pay fell to $49,912 while the national figure held near $47,840, narrowing what had likely been a local premium. A cooling local rate alongside tight unemployment (3.3% New Hanover County) suggests softer demand for entry-level lab talent even as mid-career scientific and regulatory roles tighten — a signal worth separating from broader 'lab talent shortage' narratives.
State-level manufacturing scale-ups widen the competitive radius for specialists.
NC's 91 announced life sciences projects since 2022, including Amgen and J&J expansions, concentrate specialized quality and CMC hiring demand in the Triangle and Wilson County. Wilmington employers drawing from the same statewide talent pool should expect increased competition for mid-career manufacturing and quality talent even without direct local project announcements.
Median advertised pay by role — Wilmington, NC MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $109,698 | $126,649 | $126,649 | Significant decline | $130,339 |
| Clinical Research Associate | $59,708 | $73,589 | $98,734 | Significant increase | $90,065 |
| Lab Technician * | $41,303 | $49,912 | $56,836 | Significant decline | $47,840 |
| Regulatory Affairs Specialist * | $78,659 | $119,186 | $119,783 | Significant increase | $103,780 |
| Clinical Data Manager * | $98,797 | $118,202 | $121,795 | Stable | $123,653 |
| Biostatistician | $113,343 | $113,781 | $128,833 | Stable | $131,958 |
| Validation Engineer | $92,540 | $92,540 | $92,540 | Stable | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
New Hanover County's unemployment rate sat at 3.3% in August, down 0.4 points year-over-year, reflecting a metro labor market still tighter than the national 4.2% rate and reinforcing that life sciences employers here compete for scientific and regulatory talent against a backdrop of broader scarcity. Statewide manufacturing capacity expansion — including Amgen's Holly Springs buildout and J&J's $2B Wilson County campus — is pulling specialized quality and CMC talent toward large-scale in-state operators, intensifying competition for the same credentialed pool that Wilmington-area biotech, CRO, and device employers depend on.
What it means
Wilmington's regulatory affairs advertised pay climbed to a $119,186 metro median — above the $103,780 national figure, which moved down — while clinical research associate pay rose to $73,589 locally yet still trails the $90,065 national median by a wide margin, suggesting the metro pays a premium to retain regulatory talent but may be underpricing CRA roles relative to where national competition for experienced clinical operations staff is heading. Divergence across roles argues against flat cost-of-living adjustments and for role-specific benchmarking tied to national CRA and CMC scarcity, particularly as in-state manufacturing scale-ups elsewhere in North Carolina widen the radius from which local employers must recruit. Consider reviewing CRA compensation positioning against national movement before losing experienced clinical operations staff to employers outside the metro.
Looking ahead
Worth watching: October metro-level unemployment and employment data won't publish until December 2; the closest current proxy remains August's 3.3% New Hanover County rate. Treat any near-term local labor market read as a lagging signal until the full metro release lands.
Emerging pressure point: National CRA and CMC/biomanufacturing roles remain the hardest to fill per industry surveys, while Wilmington's CRA pay still trails the national median by nearly $16,500. Watch whether this gap widens further as NC's in-state biologics expansions pull experienced clinical and manufacturing talent toward Holly Springs and Wilson County.
Potential inflection point: Nationally, biopharma layoffs are down sharply year-over-year and 64% of organizations report active recruiting, yet the national quit rate sits at just 1.9%. A tight supply of experienced candidates nationally means local openings in regulatory or clinical roles may stay unfilled longer even as hiring intent increases.
Early indicator: North Carolina's upper-half wage growth (4.2%) continues to outpace bottom-quartile growth (3.5%), a divergence that tracks closely with Wilmington's role-specific pay data showing regulatory affairs and CRA pay rising while lab technician pay softens. Expect this bifurcation to sharpen compensation planning conversations heading into 2027 budget cycles.
Sources
- NC Department of Commerce / BLS — New Hanover County unemployment at 3.3% in August 2026, down 0.4pt YoY
- NCBiotech / state economic development reporting — Amgen Holly Springs and J&J Wilson County expansions
- Industry life sciences workforce survey — National CRA roles are the hardest to fill, experienced CRAs are the bottleneck
- Life sciences industry labor market research — Biopharma Q3 layoffs down 90% YoY; 64% of organizations actively recruiting
- Bureau of Labor Statistics — National quit rate at 1.9%
- North Carolina Biotechnology Center — NC life sciences investment: 91 projects, $19B, 10,000+ jobs since 2022
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.